Skip navigation
Skip to main content

Browsing by Author Zannino, Diana

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:  
Showing results 1 to 4 of 4
PreviewIssue DateTitleAuthor(s)
14-Dec-2015The cost effectiveness of bevacizumab when added to capecitabine, with or without mitomycin-C, in first line treatment of metastatic colorectal cancer: results from the Australasian phase III MAX studyCarter, Hannah; Zannino, Diana; Simes, R John; Schofield, Deborah J; Howard, Kirsten; Zalcberg, John R; Price, Timothy J; Tebbutt, Niall C
Jan-2011Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyDrury, Paul L; Ting, Ru-Dee; Zannino, Diana; Ehnholm, Christian; Flack, Jeff; Whiting, Malcolm; Fassett, Robert; Ansquer, Jean-Claud; Dixon, Paul; Davis, Timothy ME; Pardy, Christopher; Colman, Peter; Keech, Anthony
23-Aug-2014Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyD'Emden, Michael C; Jenkins, Alicia J; Li, Liping; Zannino, Diana; Mann, Kristy P; Best, James D; Stuckey, Bronwyn GA; Park, Kris; Saltevo, Juha; Keech, Anthony C
15-Oct-2014Sentinel-lymph-node-based management or routine axillary clearance? Three-year outcomes of the RACS Sentinel Node Biopsy versus Axillary Clearance (SNAC) 1 trialWetzig, Neil; Gill, Peter Grantley; Zannino, Diana; Stockler, Martin R; Gebski, Val; Ung, Owen; Campbell, Ian; Simes, R John